SCHEMBL30140107

SCHEMBL30140107

Fc1cc2ncnc(Nc3ccc(Cl)c(F)c3F)c2nc1O[C@H]1CCNC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.39
HTR1A P08908 4/20 0.36
SLC6A2 P23975 4/20 0.36
FLT1 P17948 2/20 0.36
KDR P35968 2/20 0.36
FGFR1 P11362 1/20 0.36
FLT4 P35916 1/20 0.36
GPR119 Q8TDV5 2/20 0.35
ERBB2 P04626 2/20 0.35
EPHB4 P54760 2/20 0.35
RIPK2 O43353 1/20 0.35
RET P07949 1/20 0.35
MET P08581 1/20 0.35
EPHB2 P29323 1/20 0.35
TEC P42680 1/20 0.35
EPHA4 P54764 1/20 0.35
BTK Q06187 1/20 0.35
KCNH2 Q12809 1/20 0.35
TNK1 Q13470 1/20 0.35
RIPK3 Q9Y572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23538160 0.92 EGFR (0.45) EGFRHTR1ASLC6A2FLT1KDR
SCHEMBL23538163 0.92 EGFR (0.45) EGFRHTR1ASLC6A2FLT1KDR
SCHEMBL30140412 0.87 KDR (0.43) EGFRFLT1KDRFGFR1FLT4
SCHEMBL30140366 0.87 GPR119 (0.37) EGFRFLT1KDRFGFR1FLT4
SCHEMBL30140353 0.87 KDR (0.44) EGFRFLT1KDRFGFR1FLT4
SCHEMBL30140086 0.86 EGFR (0.35) EGFRHTR1ASLC6A2FLT1KDR
SCHEMBL30140272 0.86 EGFR (0.37) EGFRHTR1ASLC6A2FLT1KDR
SCHEMBL30140153 0.85 EGFR (0.43) EGFRHTR1ASLC6A2FLT1KDR
SCHEMBL30140375 0.84 GPR119 (0.38) EGFRFLT1KDRFGFR1FLT4
SCHEMBL30140218 0.81 EPHA2 (0.42) EGFRFLT1KDRFGFR1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed